Ralf Bender's Selected Bibliography
Go to:
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000 and before
-
-
BENDER, R.(2012):
Adequate methods should be used to compare the features of effect measures.
J. Clin. Epidemiol. 65 (in press).
-
BENDA, N. & BENDER, R.(2011):
Multiplicity issues in clinical trials.
Biom. J. 53, 873-874.
-
BENDER, R. & VERVÖLGYI, V. (2011):
Die Berechnung adjustierter NNTs in randomisierten kontrollierten Studien.
In: ORTSEIFEN, C., RAMROTH, H., WEIRES, M. & MINKENBERG, R. (Eds.):
KSFE 2011 − Voneinander lernen”, Proceedings der 15. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE),
Ruprechts-Karls-Universität Heidelberg, 24.-25.02.2011, pp. 51-58. Shaker, Aachen.

-
VERVÖLGYI, E., KROMP, M., SKIPKA, G., BENDER, R. & KAISER, T.(2011):
Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: A literature survey.
BMC Med. Res. Methodol. 11, 130.

-
BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S. (2011):
The assessment of heterogeneity is mandatory in clinical trials and systematic reviews.
J. Clin. Epidemiol. 64, 452.
-
BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S (2010):
No inconsistent trial assessments by NICE and IQWiG: Different assessment goals may lead to different assessment results regarding subgroup analyses.
J. Clin. Epidemiol. 63, 1305-1307.
-
SKIPKA, G. & BENDER, R. (2010):
Assessment of intervention effects in the case of heterogeneity between three subgroups within the framework of systematic reviews.
Meth. Inf. Med. 49, 613-617.
-
GEHRMANN, U., KUSS, O., WELLMANN, J. & BENDER, R. (2010):
Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates.
J. Clin. Epidemiol. 63, 1223-1231.
-
BENDER, R. (2010):
Using and interpreting adjusted NNT measures in biomedical research.
Open Dent. J. 4, 72-76.

-
BENDER, R. & VERVÖLGYI, V. (2010):
Estimating adjusted NNTs in randomised controlled trials with binary outcomes: A simulation study.
Contemp. Clin. Trials 31, 498-505.
-
STANG, A., POOLE, C. & BENDER, R. (2010):
Common problems related to the use of number needed to treat.
J. Clin. Epidemiol. 63, 820-825.
-
HORVATH, K., KOCH, K., JEITLER, K., MATYAS, E., BENDER, R.,
BASTIAN, H., LANGE, S. & SIEBENHOFER, A. (2010):
Effects of treatment in women with gestational diabetes mellitus: Systematic review and meta-analysis.
BMJ 340, c1395.

-
LAUBENDER, R.P. & BENDER, R. (2010):
Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.
Stat. Med. 29, 851-859.
-
BENDER, R. & KUSS, O. (2010):
Methods to calculate relative risks, risk differences, and numbers needed to treat from logistic regression.
J. Clin. Epidemiol. 63, 7-8.
-
GROUVEN, U., HEMKENS, L.G., BENDER, R. & SAWICKI, P.T. (2010):
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter].
Diabetologia 53, 209-211.
-
HEMKENS, L.G., BENDER, R., GROUVEN, U. & SAWICKI, P.T. (2009):
Insulin glargine and cancer.
Lancet 374, 1743-1744.

-
HEMKENS, L.G., GROUVEN, U., BENDER, R., GÜNSTER, C.,
GUTSCHMIDT, S., SELKE, G.W. & SAWICKI, P.T. (2009):
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study.
Diabetologia 52, 1732-1744.

-
HILDEBRANDT, M., VERVÖLGYI, E. & BENDER, R. (2009):
Calculation of NNTs in RCTs with time-to-event outcomes: A literature review.
BMC Med. Res. Methodol. 9, 21.

-
LÜHRMANN, P.M., BENDER, R., EDELMANN-SCHÄFER, B. & NEUHÄUSER-BERTHOLD, M. (2009):
Longitudinal changes in energy expenditure in an elderly German population: A 12 year follow-up.
Eur. J. Clin. Nutr. 63, 986-992.
-
BENDER, R. (2009):
Introduction to the use of regression models in epidemiology.
In: VERMA, M. (Ed.):
Cancer Epidemiology, Vol. 1: Host Susceptibility Factors,
pp. 179-195. Humana Press, Totowa, NJ.
-
GROUVEN, U., KÜCHENHOFF, H., SCHRÄDER, P. & BENDER, R. (2008):
Flexible regression models are useful tools to calculate and assess threshold values in the context of minimum provider volumes.
J. Clin. Epidemiol. 61, 1125-1131.
-
BENDER, R. & GROUVEN, U. (2008):
Berechnung von Konfidenzintervallen für die Population Impact Number (PIN).
In: HILGERS, R.-D., HEUSSEN, N., HERFF, W. & ORTSEIFEN, C. (Eds.):
KSFE 2008 − Proceedings der 12. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE),
pp. 41-47. Shaker, Aachen.

-
BENDER, R., BUNCE, C., CLARKE, M., GATES, S., LANGE, S., PACE, N.L.
& THORLUND, K. (2008):
Attention should be given to multiplicity issues in systematic reviews.
J. Clin. Epidemiol. 61, 857-865.
-
BENDER, R. (2007):
Simulation von Überlebenszeiten mit Hilfe von SAS®.
In: MUCHE, R. & BÖDEKER, R.-H. (Eds.):
KSFE 2007 − Proceedings der 11. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE),
pp. 55-62. Shaker, Aachen.

-
BENDER, R., KUSS, O., HILDEBRANDT, M. & GEHRMANN, U. (2007):
Estimating adjusted NNT measures in logistic regression analysis.
Stat. Med. 26, 5586-5595.
-
SCHRÄDER, P., GROUVEN, U. & BENDER, R. (2007):
Können Mindestmengen für Knieprothesen anhand von Routinedaten errechnet werden?
Ergebnisse einer Schwellenwertanalyse mit Daten der externen stationären Qualitätssicherung.
Orthopäde 36, 570-576.
-
LANGE, S. & BENDER, R. (2007): Median oder Mittelwert?
Dtsch. Med. Wschr. 132, e1-e2.

-
LANGE, S. & BENDER, R. (2007): Quantile, empirische Verteilungsfunktion und Box Plot.
Dtsch. Med. Wschr. 132, e3-e4.

-
LANGE, S. & BENDER, R. (2007): Variabilitätsmaße.
Dtsch. Med. Wschr. 132, e5-e6.

-
LANGE, S. & BENDER, R. (2007): Das Histogramm.
Dtsch. Med. Wschr. 132, e7-e8.

-
LANGE, S. & BENDER, R. (2007): Lineare Regression und Korrelation.
Dtsch. Med. Wschr. 132, e9-e11.

-
BENDER, R. & LANGE, S. (2007): Die Vierfeldertafel.
Dtsch. Med. Wschr. 132, e12-e14.

-
BENDER, R. & LANGE, S. (2007): Was ist der p-Wert?
Dtsch. Med. Wschr. 132, e15-e16.

-
BENDER, R. & LANGE, S. (2007): Was ist ein Konfidenzintervall?
Dtsch. Med. Wschr. 132, e17-e18.

-
LANGE, S. & BENDER, R. (2007): Was ist ein Signifikanztest? Allgemeine Aspekte.
Dtsch. Med. Wschr. 132, e19-e21.

-
BENDER, R. & LANGE, S. (2007): Verlaufskurven.
Dtsch. Med. Wschr. 132, e22-e23.

-
BENDER, R., LANGE, S. & ZIEGLER, A. (2007): Wichtige Signifikanztests.
Dtsch. Med. Wschr. 132, e24-e25.

-
BENDER, R., LANGE, S. & ZIEGLER, A. (2007): Multiples Testen.
Dtsch. Med. Wschr. 132, e26-e29.

-
BENDER, R., ZIEGLER, A. & LANGE, S. (2007): Multiple Regression.
Dtsch. Med. Wschr. 132, e30-e32.

-
BENDER, R., ZIEGLER, A. & LANGE, S. (2007): Logistische Regression.
Dtsch. Med. Wschr. 132, e33-e35.

-
ZIEGLER, A., LANGE, S. & BENDER, R. (2007): Überlebenszeitanalyse: Eigenschaften und Kaplan-Meier Methode.
Dtsch. Med. Wschr. 132, e36-e38.

-
ZIEGLER, A., LANGE, S. & BENDER, R. (2007): Überlebenszeitanalyse: Der Log-Rang-Test.
Dtsch. Med. Wschr. 132, e38-e41.

-
ZIEGLER, A., LANGE, S. & BENDER, R. (2007): Überlebenszeitanalyse: Die Cox-Regression.
Dtsch. Med. Wschr. 132, e42-e44.

-
KLUG, S., BENDER, R., BLETTNER, M. & LANGE, S. (2007):
Wichtige epidemiologische Studientypen.
Dtsch. Med. Wschr. 132, e45-e47.

-
ZIEGLER, A., LANGE, S. & BENDER, R. (2007): Systematische Übersichten und Meta-Analysen.
Dtsch. Med. Wschr. 132, e48-e52.

-
LANGE, S., BENDER, R. & ZIEGLER, A. (2007): Äquivalenzstudien und Nichtunterlegenheitsstudien.
Dtsch. Med. Wschr. 132, e53-e56.

-
BENDER, R., ZIEGLER, A. & LANGE, S. (2007): Varianzanalyse.
Dtsch. Med. Wschr. 132, e57-e60.

-
BENDER, R., GROUVEN & ZIEGLER, A. (2007): Varianzanalyse für Messwertwiederholungen.
Dtsch. Med. Wschr. 132, e61-e64.

-
GROUVEN, U., BENDER, R., ZIEGLER, A. & LANGE, S. (2007): Der Kappa-Koeffizient.
Dtsch. Med. Wschr. 132, e65-e68.

-
GROUVEN, BENDER, R., ZIEGLER, A. & LANGE, S. (2007): Vergleich von Messmethoden.
Dtsch. Med. Wschr. 132, e69-e73.

-
KÜCHENHOFF, H., BENDER, R. & LANGNER, I. (2007):
Effect of Berkson measurement error on parameter estimates in Cox regression models.
Lifetime Data Anal. 13, 261-272.
-
KUTSCHMANN, M., BENDER, R., GROUVEN, U. & BERG, G. (2006):
Aspekte der Fallzahlkalkulation und Powerberechnung anhand von Beispielen aus der rehabilitationswissenschaftlichen Forschung.
Rehabilitation 45, 377-384.
-
BENDER, R., ZEEB, H., SCHWARZ, M., JÖCKEL, K.-H. & BERGER, M. (2006):
Causes of death in obesity: Relevant increase in cardiovascular but not in all-cancer mortality.
J. Clin. Epidemiol. 59, 1064-1071.
-
HILDEBRANDT, M., BENDER, R., GEHRMANN, U. & BLETTNER, M. (2006):
Calculating confidence intervals for impact numbers.
BMC Med. Res. Methodol. 6, 32.

-
BENDER, R., HILDEBRANDT, M. & KUSS, O. (2006):
Die Berechnung adjustierter NNEs in Kohortenstudien.
In: KAISER, K. & BÖDEKER, R.-H. (Eds.): Statistik und Datenanalyse mit SAS® − Proceedings der
10. Konferenz für SAS-Anwender in Forschung und Entwicklung (KSFE),
pp. 19-33. Shaker, Aachen.

-
BENDER, R. & GROUVEN, U. (2006):
Möglichkeiten und Grenzen statistischer Regressionsmodelle zur Berechnung von Schwellenwerten für Mindestmengen.
Z. ärztl. Fortbild. Qual. Gesundh.wes. 100, 93-98.
-
SAWICKI, P.T., BENDER, R., SELKE, G.W., KLAUBER, J. & GUTSCHMIDT, S. (2006):
Schätzung der unter Rofecoxib (Vioxx®) in Deutschland in den Jahren 2001-2004 aufgetretenen kardio- und zerebrovaskulären Ereignisse.
Med. Klin. 101, 191-197 .
-
BENDER, R., AUGUSTIN, T. & BLETTNER, H.(2005):
Generating survival times to simulate Cox proportional hazards models.
Stat. Med. 24, 1713-1723.
Corresponding Letter:
Stat. Med. 25 (2006), 1978-1979.
-
BENDER, R., BERG, G. & ZEEB, H. (2005):
Tutorial: Using confidence curves in medical research.
Biom. J. 47, 237-247.
-
MEYER, G., KÖPKE, S., BENDER, R., & MÜHLHAUSER, I. (2005):
Predicting the risk of falling - efficacy of a risk assessment tool compared to nurses' judgement: A cluster-randomised controlled trial [ISRCTN37794278].
BMC Geriatr. 5, 14.

-
SÄMANN, A., MÜHLHAUSER, I., BENDER, R., KLOOS, C & MÜLLER, U.A. (2005):
Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: Prospective implementation study.
Diabetologia 48, 1965-1970.

-
BENDER, R. (2005):
Number needed to treat (NNT).
In: ARMITAGE, P. & COLTON, T. (Eds.):
Encyclopedia of Biostatistics, Vol. 6 (2nd Ed.), pp. 3752-3761.
Wiley, Chichester.
-
WARNKE, A., MEYER, G., BENDER, R. & MÜHLHAUSER, I. (2004):
Predictors of adherence to the use of hip protectors in nursing home residents.
J. Am. Geriatr. Soc. 52, 340-345.
-
LOBNIG, B.M., MASLOWSKA-WESSEL, E. & BENDER, R. (2003):
Repeatability of heart rate variability measured via spectral analysis in healthy subjects.
J. Clin. Basic Cardiol. 6, 29-33.

-
BENDER, R. & KUSS, O. (2003):
Confidence intervals for adjusted NNEs: A simulation study (Letter).
J. Clin. Epidemiol. 56, 205-206.
-
SEYDEL, J., ULLRICH, A., BENDER, R.,
FISCHBACH, W. & BLETTNER, M. (2003):
Helicobacter pylori and carcinogenesis of gastric B-cell lymphomas.
Int. J. Cancer 104, 646-649.

-
MEYER, G., WARNKE, A., BENDER, R. &
MÜHLHAUSER, I. (2003):
Effect on hip fractures of increased use of hip protectors in nursing homes: Cluster randomised controlled trial.
BMJ 326, 76-78.

-
BENDER, R., JÖCKEL, K.-H., RICHTER, B., SPRAUL, M. &
BERGER, M. (2002):
Body weight, blood pressure, and mortality in a cohort of obese patients.
Am. J. Epidemiol. 156, 239-245.

-
BENDER, R. & BLETTNER, M. (2002):
Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies.
J. Clin. Epidemiol. 55, 525-530.
-
BENDER, R. (2002):
Reply to "Simple and effective confidence intervals for the number needed to treat".
Control. Clin. Trials 23, 101-102.
-
SADDIG, C., BENDER, R. & STARKE, A.A.R. (2002):
A new classification plot for the C-peptide suppression test.
J. Pancreas 3, 16-25.

-
MEINHOLD, J., MASLOWSKA-WESSEL, E.,
BENDER, R. & SAWOCKI, P.T. (2001):
Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy.
Diabet. Med. 18, 607-613.
-
BENDER, R. & LANGE, S. (2001):
Adjusting for multiple testing - when and how ?
J. Clin. Epidemiol. 54, 343-349.
-
BENDER, R. (2001):
Calculating confidence intervals for the number needed to treat.
Control. Clin. Trials 22, 102-110.
-
BENDER, R. (2001):
Interpretation von Effizienzmaßen der Vierfeldertafel für Diagnostik und Behandlung.
Med. Klin. 96, 116-121. Correction: Med. Klin. 96, 181.
-
BENDER, R. (2000):
Calculating summary measures of unimodal response curves by means of
nonlinear regression models.
J. Theor. Med. 2, 73-89.
-
MÜHLHAUSER, I., OVERMANN, H., BENDER, R.,
JÖRGENS, V. & BERGER, M. (2000):
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified
insulin therapy.
Diabet. Med. 17, 727-734.
-
MÜHLHAUSER, I., SAWICKI, P.T., BLANK, M., OVERMANN, H.,
BENDER, R. & BERGER, M. (2000):
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy.
J. Intern. Med. 248, 333-341.

-
BENDER, R. & BENNER, A. (2000):
Calculating ordinal regression models in SAS and S-Plus.
Biom. J. 42, 677-699.
-
BENDER, R. (2000):
Improving the calculation of confidence intervals for the number needed to treat.
In: HASMAN, A., BLOBEL, B., DUDECK, J., ENGELBRECHT, R.,
GELL, G. & PROKOSCH, H.-U. (Eds.):
Medical Infobahn for Europe (Proc. of the MIE2000 and GMDS2000), pp. 29-32.
IOS Press, Amsterdam.
-
BENDER, R. (2000):
Berechnung von Konfidenzintervallen für die Zahl "Number Needed to Treat" (NNT).
In: BÖDEKER, R.-H. & HOLLENHORST, M. (Eds.):
Proc. der 4. Konferenz für SAS-Anwender in Forschung und Entwicklung , pp. 1-7.
AG Statistik des Inst. für Med. Informatik, Gießen.

-
RICHTER, B., BENDER, R. & BERGER, M.(2000):
Effects of on-demand ß2-agonist inhalation in
moderate-to-severe asthma. A randomized controlled trial.
J. Intern. Med. 247, 657-666.

-
SAWICKI, P.T., BENDER, R., BERGER, M. &
MÜHLHAUSER, I. (2000):
Non-linear effects of blood pressure and glycosylated haemoglobin on progression of
diabetic nephropathy.
J. Intern. Med. 247, 131-138.

-
RICHTER, B. & BENDER, R. (2000):
Kritische Bewertung von Theraphieverfahren.
In: BERGER, M. (Hrsg.): Diabetes mellitus (2. Aufl.), pp. 223-233.
Urban & Fischer, München.
-
BENDER, R. & KIMMERLE, R. (1999):
Assessment of glycemic thresholds for fetal macrosomia in pregnant diabetic women.
In: VICTOR, N., BLETTNER, M., EDLER, L.,
HAUX, R., KNAUP-GREGORI, P., PRITSCH, M.,
WAHRENDORF, J., WINDELER, J. & ZIEGLER, S. (Eds.):
Medical Informatics, Biostatistics and Epidemiology for Efficient Health Care and
Medical Research (Contributions from the 44th Annual Conference of the GMDS), pp. 115-116.
Urban & Vogel, München.
-
TROCHA, A., SCHMIDTKE, C., DIDJURGEIT, U.,
MÜHLHAUSER, I., BENDER, R., BERGER, M. &
SAWICKI, P.T. (1999):
Effects of intensified antihypertensive treatment in diabetic nephropathy:
Mortality and morbidity results of a prospective controlled 10-year study.
J. Hypertens. 17, 1497-1503.
-
BENDER, R. (1999):
Quantitative risk assessment in epidemiological studies investigating threshold effects.
Biom. J. 41, 305-319.
-
BENDER, R., JÖCKEL, K.-H., TRAUTNER, C.,
SPRAUL, M. & BERGER, M. (1999):
Effect of age on excess mortality in obesity.
JAMA 281, 1498-1504.

-
RAVE, K., BENDER, R., HEISE, T.
& SAWICKI, P.T. (1999):
Value of blood pressure self-monitoring as a predictor of progression of diabetic
nephropathy.
J. Hypertens. 17, 597-601.
-
BENDER, R. & LANGE, S. (1999):
Multiple test procedures other than Bonferroni's deserve wider use (Letter).
BMJ 318, 600-601.
-
KIMMMERLE, R., HEINEMANN, L., HEISE, T.,
BENDER, R., WEYER, C., HIRSCHBERGER, S. &
BERGER, M. (1999):
Influence of continuous combined estradiol-norethisterone acetate preparations on
insulin sensitivity in postmenopausal nondiabetic women.
Menopause 6, 36-42.
-
MÜHLHAUSER, I., OVERMANN, H., BENDER, R.,
BOTT, U., & BERGER, M. (1998):
Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes -
a prospective population based study.
Diabetologia 41, 1274-1282.

-
MÜHLHAUSER, I., OVERMANN, H., BENDER, R.,
BOTT, U., JÖRGENS, V., TRAUTNER, C.,
SIEGRIST, J. & BERGER, M. (1998):
Social status and the quality of care for adult people with Type I (insulin-dependent)
diabetes mellitus - a population based study.
Diabetologia 41, 1139-1150.

-
BENDER, R. & GROUVEN, U. (1998):
Using binary logistic regression models for ordinal data with non-proportional odds.
J. Clin. Epidemiol. 51, 809-816.
-
BENDER, R., LANGE, S., FREITAG, M.
& TRAMPISCH, H.J. (1998):
Variation of sensitivity, specificity, likelihood ratios and predictive values with
disease prevalence (Letter).
Statist. Med. 17, 946-947.
-
BENDER, R., TRAUTNER, C., SPRAUL, M.
& BERGER, M. (1998):
Assessment of excess mortality in obesity.
Am. J. Epidemiol. 147, 42-48.

-
SAWICKI, P.T., KIWITT, S., BENDER, R.
& BERGER, M. (1998):
The value of the QT interval dispersion for identification of total mortality
risk in non-insulin-dependent diabetes mellitus.
J. Intern. Med. 243, 49-56.

-
BENDER, R. & GROUVEN, U. (1997):
Ordinal logistic regression in medical research.
J. R. Coll. Physic. London 31, 546-551.
-
BENDER, R., TRAUTNER, C, SPRAUL, M.
& BERGER, M. (1997):
Die Übersterblichkeit bei Übergewicht − Die Düsseldorf Obesity Mortality Study (DOMS).
In: MUCHE, R., BÜCHELE, G., HARDER, D.
& GAUS, W. (Eds.):
Medizinische Informatik, Biometrie und Epidemiologie − GMDS '97
(Proc. 42. Jahrestagung der GMDS e.V.), pp. 459-463.
MMV Medizin Verlag, München.
-
BENDER, R. (1997):
Square dance and probability (Letter).
EAASDC Bull. 18 (No. 5), 19-20.
-
BENDER, R. & GROUVEN, U. (1996):
Logistic regression models used in medical research are poorly presented (Letter).
BMJ 313, 628.
-
BENDER, R. (1996):
Calculating confidence intervals for summary measures of individual curves via nonlinear regression.
Int. J. Biomed. Comput. 41, 13-18.
-
BENDER, R. (1996):
The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved (Letter).
Diabetologia 39, 368-369.
-
MÜHLHAUSER, I., BENDER, R., BOTT, U.,
JÖRGENS, V., GRÜSSER, M., WAGENER, W.,
OVERMANN, H. & BERGER, M. (1996):
Cigarette smoking and progression of retinopathy and nephropathy in Type 1 diabetes.
Diabet. Med. 13, 536-543.
-
MÜHLHAUSER, I., PRANGE, K., SAWICKI, P.T.,
BENDER, R., DWORSCHAK, A., SCHADEN, W.
& BERGER, M. (1996):
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Diabetologia 39, 212-219.
-
SAWICKI, P.T., DÄHNE, R., BENDER, R.
& BERGER, M. (1996):
Prolonged QT interval as a predictor of mortality in diabetic nephropathy.
Diabetologia 39, 77-81.
-
BENDER, R. & SAWICKI, P.T. (1996):
Effect of intensive treatment in insulin dependent diabetes mellitus with microalbuminuria
(Letter).
BMJ 312, 254.
-
HEINEMANN, L., HEISE, T., KLEPPER, A.,
AMPUDIA, J., BENDER, R. & STARKE, A.A.R. (1995):
Time action profiles of the intermediate-acting insulin analogue:
Des(64,65)-human proinsulin.
Diabetes Metab. 21, 415-419.
-
BENDER, R. & HEINEMANN, L. (1995):
Fitting nonlinear regression models with correlated errors to individual pharmacodynamic
data using SAS software.
J. Pharmacokin. Biopharm. 23, 87-100.
-
SAWICKI, P.T., MÜHLHAUSER, I., DIDJURGEIT, U.,
BAUMGARTNER, A., BENDER, R. & BERGER, M. (1995):
Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic
patients with nephropathy.
J. Hypertens. 13, 933-938.
-
MÜHLHAUSER, I., BOTT, U., OVERMANN, H.,
WAGENER, W., BENDER, R., JÖRGENS, V.
& BERGER, M. (1995):
Liberalized diet in patients with type 1 diabetes.
J. Intern. Med. 237, 591-597.
-
KIMMERLE, R, ZAß, R.-P., SOMVILLE, T.,
BENDER, R., PAWLOWSKI, B. & BERGER, M. (1995):
Pregnancies in women with diabetic nephropathy: Long-term outcome for mother and child.
Diabetologia 38, 227-235.
-
BENDER, R. & HEINEMANN, L. (1994):
Description of peaked curves by means of exponential functions.
In: PÖPPL, S.J., LIPINSKI, H.-G. & MANSKY, T.
(Eds.): Medizinische Informatik: Ein integrierender Teil arztunterstützender
Technologien (Proc. 38. Jahrestagung der GMDS e.V.), pp. 482-485.
MMV, München.
-
BENDER, R. (1994):
Determination of the area under a curve (Letter).
Diabetes Care 17, 1223.
-
SAWICKI, P.T., DIDJURGEIT, U., MÜHLHAUSER, I.,
BENDER, R., HEINEMANN, L. & BERGER, M. (1994):
Smoking is associated with progression of diabetic nephropathy.
Diabetes Care 17, 126-131.
-
BENDER, R. (1993):
Using common statistical program packages for the Friedman test when ties are among treatments
and a multiple comparison procedure is needed.
Comput. Statist. Data Anal. 16, 365-369.
-
BENDER, R. & GROUVEN, U. (1993):
On the choice of the number of residual autocovariances for the portmanteau test
of multivariate autoregressive models.
Commun. Statist. - B 22, 19-32.
-
BENDER, R., SCHULTZ, B. & GROUVEN, U. (1993):
Classification of EEG signals into general stages of anesthesia in real-time
using autoregressive models.
In: OPITZ, O., LAUSEN, B. & KLAR, R. (Eds.):
Information and Classification: Concepts, Methods and Application
(Proc. of the 16th Annual Conference of the "Gesellschaft für Klassifikation"), pp. 443-452.
Springer, Berlin.
-
SCHULTZ, B., BENDER, R., SCHULTZ, A. &
PICHLMAYR, I. (1992):
Reduktion der Anzahl von EEG-Ableitung für ein routinemäßiges
Monitoring auf der Intensivstation.
Biomed. Techn. 37, 194-199.
-
GROUVEN, U., BENDER, R., SCHULTZ, A. &
PICHLMAYR, R. (1992):
Application of adjusted survival curves to renal transplant data.
Meth. Inf. Med. 31, 210-214.

-
BENDER, R., SCHULTZ, B., SCHULTZ, A. &
PICHLMAYR, I. (1992):
Testing the Gaussianity of the human EEG during anesthesia.
Meth. Inf. Med. 31, 56-59.

-
BENDER, R., SCHULTZ, B., SCHULTZ, A. &
PICHLMAYR, I. (1991):
Identification of EEG patterns occuring in anesthesia by means of autoregressive parameters.
Biomed. Techn. 36, 236-240.
-
BENDER, R. & WOLTERING, F. (1991):
Heritabilitätsschätzungen bei ordinalen Daten.
Forschungsbericht Nr. 91/1,
FB Statistik der Universität Dortmund.
Do you need a reprint?
Send me a request:
Ralf.Bender@iqwig.de
Back to my statistics page
Back to my start page
© 30.01.2012 Ralf Bender